Finance and markets: business, quotes, gold, energy and releases.
Found 2234 articles
Haemonetics has received FDA 510(k) clearance for its NexSys PCS system featuring Persona PLUS technology, a software-driven upgrade designed to maximize donation volumes and improve efficiency for plasma collectors.
Diamondback Energy reported a significant fourth-quarter loss on Monday, driven by a multibillion-dollar write-down of asset values as crude prices retreated. The Midland, Texas-based producer swung to a net loss of $1.46 billion, or $5.11 per share, a sharp reversal from the $1.07 billion profit recorded during the same period last year.
Diamondback Energy reported a $1.46 billion net loss for the fourth quarter, missing analyst earnings estimates as the Texas-based producer navigates a "yellow light" macroeconomic environment defined by global oversupply.
Kratos Defense & Security Solutions reported fourth-quarter results on Monday that exceeded Wall Street expectations, fueled by a 22% revenue surge in its government solutions division. The contractor posted adjusted earnings of 18 cents per share on revenue of $345.1 million, outperforming analyst forecasts despite looming headwinds from federal budget delays.
Utility providers across New York and New Jersey are making headway in restoring electricity to thousands of households after a severe winter storm battered the Northeast with blizzard conditions and high winds.
GSK has renewed its strategic manufacturing partnership with Bora Pharmaceuticals for an additional five years, solidifying a supply chain that spans North America. The agreement extends a relationship established in 2020, ensuring the continued production of over 20 commercial products while granting the British drugmaker access to Bora’s expanding facility network.
Home Depot is expected to report a decline in fourth-quarter revenue and earnings on Tuesday, as high mortgage rates and economic uncertainty continue to stifle the home-improvement sector. Analysts surveyed by FactSet project a contraction in both top- and bottom-line figures, marking a cautious end to the fiscal year for the retail giant.
Bayer has filed a lawsuit against Johnson & Johnson and its Janssen Biotech unit, alleging the pharmaceutical giant used deceptive marketing to promote its prostate cancer treatment, Erleada. The legal challenge disputes J&J's claims that its drug is superior to Bayer’s competing therapy, Nubeqa, marking a significant escalation in the competition for dominance in the oncology sector.
Amazon is pouring $12 billion into northwest Louisiana to develop a massive network of data-center campuses, a move designed to bolster its artificial intelligence and cloud computing infrastructure. The investment, announced Monday, marks a significant expansion for the tech giant in the South, aiming to drive regional economic growth through infrastructure upgrades and job creation.
Wheat prices on the Chicago Board of Trade dropped on Monday as favorable weather forecasts for the U.S. and Russia mitigated supply fears, while corn futures found modest support from a surge in export inspections and shifting fund positions.
Bayer has filed a lawsuit against Johnson & Johnson and its Janssen Biotech unit, alleging that marketing claims for the prostate-cancer drug Erleada are based on "scientifically flawed" data. The litigation contests J&J’s recent assertions that its treatment is significantly more effective than Bayer’s rival drug, Nubeqa.
A powerful winter storm packing heavy snow and high winds knocked out electricity for more than 289,000 utility customers across Massachusetts on Monday, with coastal regions bearing the brunt of the damage.
Loblaw Cos. is accelerating its shift toward value-based retail, announcing a C$2.4 billion investment to open 31 new discount grocery stores and renovate hundreds of existing locations across Canada. The expansion targets a consumer base increasingly strained by food prices that have surged more than 30% since 2019, according to industry data.
Toronto stocks retreated on Monday as anxieties surrounding global trade and the artificial intelligence sector weighed on tech shares, even as a high-stakes bidding war for Colombian energy assets sent Frontera Energy soaring.
Diesel futures rallied on Monday as a severe blizzard across the U.S. Northeast hampered logistics and boosted heating demand, while crude oil and gasoline markets remained largely flat ahead of key contract expirations.
A severe winter storm forced a suspension of vessel boardings across the U.S. Northeast on Monday, stalling critical fuel shipments to ports in New York, Connecticut, and Massachusetts. Maritime pilots in the region halted operations as heavy weather conditions made navigation unsafe, leaving several tankers carrying gasoline and distillates idling off the coast.
Specialty chemical manufacturer Stepan announced a sweeping operational restructuring dubbed "Project Catalyst" on Monday, involving facility closures and asset decommissioning aimed at securing $100 million in pre-tax savings over the next two years. The news triggered a 20% sell-off in the company's stock, marking its sharpest single-day decline in nearly six years as investors weighed heavy restructuring costs against softening demand.
U.S. corn export inspections surged to over 2 million metric tons for the week ended Feb. 19, significantly outpacing both previous-week and prior-year levels, according to data released Monday by the U.S. Department of Agriculture.
Shares of Frontera Energy surged more than 20% on Monday after Parex Resources submitted a $500 million cash bid for its Colombian upstream operations. The proposal significantly outsteps a previous agreement with GeoPark, offering a $125 million premium and signaling a potential bidding war for the region's oil-and-gas assets.
ImmunityBio shares rallied on Monday after the immunotherapy firm reported fourth-quarter revenue that surpassed Wall Street estimates, driven by the rapid commercial adoption of its flagship drug, Anktiva.
Lundin Gold shares surged nearly 6% on Monday following the announcement of a $670 million silver stream-for-equity agreement with LunR Royalties. The deal allows the Canadian miner to monetize silver production at its flagship Fruta del Norte mine in Ecuador while taking a significant stake in a newly formed royalty vehicle.
Atomera shares plunged 12% after the technology licensing firm announced a registered direct offering of 5 million shares priced at a significant discount to its current market value.
Rick Svetkoff, the founder of Starfighters Space, has stepped down as chief executive, paving the way for Vice President of Development Tim Franta to take the helm. The leadership transition, which includes the departure of company secretary Brenda Svetkoff, triggered a 16% drop in the company's share price.
OpenAI is partnering with Accenture, McKinsey & Co., Boston Consulting Group, and Capgemini to drive corporate adoption of its new "Frontier" agentic AI platform. The collaboration aims to bridge the gap between high-level model intelligence and practical, large-scale implementation within global enterprises.
Stanley Martin Homes has reached a definitive agreement to acquire United Homes in an all-cash transaction with an enterprise value of $221 million. The deal, priced at $1.18 per share, is expected to close in the second quarter and signals a consolidation of the Southeast’s entry-level housing market amid persistent affordability challenges.
Abits Group shares tumbled Tuesday after the cryptocurrency firm announced a $2.1 million registered direct offering priced significantly below its market value. The deal, which includes shares and pre-funded warrants, sent the stock down 25% to $2.79 as investors reacted to the dilutive capital raise.
Akamai Technologies has teamed up with Nvidia to launch a cybersecurity solution tailored for critical infrastructure, aiming to protect vulnerable power grids and factories without disrupting legacy hardware. The partnership integrates Akamai’s software with Nvidia’s BlueField Data Processing Units (DPUs) to secure industrial control systems that are often too fragile for traditional security agents.
Biopharmaceutical giant AbbVie is investing $380 million to construct two advanced manufacturing facilities at its North Chicago headquarters, targeting the high-growth neuroscience and obesity markets. The project, scheduled to begin this spring, represents a key pillar of the company's recent multibillion-dollar commitment to U.S.-based production and research.
Fortress Biotech shares jumped Monday after the company announced an agreement to sell a Rare Pediatric Disease Priority Review Voucher for $205 million in gross proceeds. The deal, executed through its subsidiary Cyprium Therapeutics, provides a significant capital injection as the firm targets a shift to profitability this year.
The U.S. Food and Drug Administration has authorized a label expansion for Eli Lilly’s weight-loss blockbuster Zepbound, introducing a multi-dose pen that provides a full month of treatment in a single device. This update transitions the medication from its previous single-dose vial format, offering a more streamlined delivery method as the pharmaceutical giant scales to meet unprecedented global demand.